Here, owing to the notable inhibitory effects on the expressions of MMP-1, MMP-3 and MMP-13 in IL-1β-induced HFLS-RAs, the treatment of plumbagin was proved to significantly attenuate the RA-induced tissue damage. The gene discussed is MMP13; the disease is rheumatoid arthritis.